Prosecution Insights
Last updated: April 19, 2026

Caribou Biosciences Inc.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
2
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18390978 TREATMENT OF AUTOIMMUNE DISEASES WITH ENGINEERED IMMUNE CELLS DUFFY, BRADLEY 1643 Non-Final OA Dec 20, 2023
18320355 COMPOSITIONS AND METHODS OF NUCLEIC ACID-TARGETING NUCLEIC ACIDS KONOPKA, CATHERINE ANNE 1635 Final Rejection May 19, 2023
17725324 CRISPR ABASIC RESTRICTED NUCLEOTIDES AND CRISPR ACCURACY VIA ANALOGS PYLA, EVELYN Y 1633 Final Rejection Apr 20, 2022

Managing Caribou Biosciences Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month